Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2025-12-09 00:00:00 ET · period of report 2025-12-08 · accession 0001579397-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-09 | 2025-12-08 | OLMA | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | G - Gift | $0.00 | -75.0K | 243.5K | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-08 | G | D | 75,000 | $0.00 | 243,549 | D | — | — |